These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum. Bacci G, Avella M, Capanna R, Boriani S, Dallari D, Galletti S, Giunti A, Madon E, Mancini A, Mercuri M. Ital J Orthop Traumatol; 1988 Mar; 14(1):23-39. PubMed ID: 3235324 [Abstract] [Full Text] [Related]
29. [Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases]. Chuman H, Fukuma H, Beppu Y. Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1736-43. PubMed ID: 2471460 [Abstract] [Full Text] [Related]
30. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma]. Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ. Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718 [Abstract] [Full Text] [Related]
31. Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma. Michelagnoli MP, Lewis IJ, Gattamaneni HR, Bailey CC, Lashford LS. Br J Cancer; 1999 Mar; 79(7-8):1174-8. PubMed ID: 10098754 [Abstract] [Full Text] [Related]
32. Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma. Leavey PJ, Mantadakis E, Maale G. Pediatr Hematol Oncol; 2002 Mar; 19(7):483-9. PubMed ID: 12217194 [Abstract] [Full Text] [Related]
33. Preoperative cisplatin for initial treatment of limb osteosarcoma: its local effect and impact on prognosis. Abe S, Nishimoto Y, Isu K, Ishii T, Goto T, Japanese Musculoskeletal Oncology Group. Cancer Chemother Pharmacol; 2002 Oct; 50(4):320-4. PubMed ID: 12357307 [Abstract] [Full Text] [Related]
36. Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European Osteosarcoma Intergroup. Lewis IJ, Weeden S, Machin D, Stark D, Craft AW. J Clin Oncol; 2000 Dec 15; 18(24):4028-37. PubMed ID: 11118463 [Abstract] [Full Text] [Related]
37. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas. Basaran M, Bavbek ES, Saglam S, Eralp L, Sakar B, Atalar AC, Bilgic B, Ozger H, Onat H. Oncology; 2007 Dec 15; 72(3-4):255-60. PubMed ID: 18185020 [Abstract] [Full Text] [Related]
40. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U, Wilke H, Seeber S. Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]